Kane Biotech Inc (TSXV:KNE) Stock News, Headlines & Updates
Kane Biotech Inc Stock News from GuruFocus
- 1
Aug 22, 2024
Kane Biotech to Release Second Quarter 2024 Financial Results on August 29, 2024 -- Conference Call to Follow
Marketwired • 4:00pm
Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyveâ„¢ Antimicrobial Wound Gel
Marketwired • 8:00am
Aug 13, 2024
Kane Biotech Receives Funding Support to Expand the revyveâ„¢ Antimicrobial Wound Gel Family
Marketwired • 8:00am
Jul 23, 2024
Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyveâ„¢ Antimicrobial Wound Gel
Marketwired • 8:00am
Jul 17, 2024
Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification
Marketwired • 8:00am
Jul 15, 2024
Kane Biotech Announces Issuance of Restricted Share Units
Marketwired • 8:00am
Jul 11, 2024
Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
Marketwired • 8:00am
Jun 27, 2024
Kane Biotech Makes First Commercial Sale of revyveâ„¢ Antimicrobial Wound Gel to ProgenaCare Global
Marketwired • 8:00am
Jun 25, 2024
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
Marketwired • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news